Raymond James Financial Inc Lexaria Bioscience Corp. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding LEXX
# of Institutions
24Shares Held
2.4MCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ1.17MShares$967,06925.66% of portfolio
-
Invenomic Capital Management LP Boston, MA501KShares$416,2180.03% of portfolio
-
Geode Capital Management, LLC Boston, MA175KShares$145,0660.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA134KShares$110,8490.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6133KShares$110,4930.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $4.94M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...